Back to Results
First PageMeta Content
C-Met / Biology / Cancer research / Protein kinase inhibitors / Protein kinase / SUGEN / Medicine / Daiichi Sankyo / Tyrosine kinase


Press Release Daiichi Sankyo Europe GmbH Zielstattstrasse[removed]Munich · Germany Phone +[removed]
Add to Reading List

Document Date: 2014-06-28 10:47:19

Open Document

File Size: 41,32 KB

Share Result on Facebook

Company

ArQule Inc. / Daiichi Sankyo Co. Ltd. / Press Release Daiichi Sankyo Europe GmbH / /

Country

United States / /

/

Event

Business Partnership / FDA Phase / /

/

IndustryTerm

chemical spaces / biotechnology / treatment of cancer / cancer therapeutics / /

MedicalCondition

cancer / small-molecule cancer / human cancers / diseases / human diseases / /

MedicalTreatment

cancer therapeutics / /

Person

Thomas C.K. Chan / Hideyuki Haruyama / /

/

Position

chief scientific officer / Global Head of Research / /

Product

adenosine / ARQ / /

Technology

drug discovery / biotechnology / AKIP™ technology / AKIP technology / /

URL

www.tcpdf.org / www.daiichi-sankyo.eu / /

SocialTag